Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
This study is ongoing, but not recruiting participants.
Study NCT00001521 Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999 Last Updated: December 11, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congenital Adrenal Hyperplasia
Growth Disorder
Additional conditions recognized in this trial
Adrenal Hyperplasia, Congenital
Adrenocortical Hyperfunction
Adrenogenital Syndrome
Disease
Growth Disorders
Hyperplasia
More general conditions related to this trial
Adrenal Gland Diseases
Endocrine System Diseases
Genetic Diseases, Inborn
Gonadal Disorders
Metabolic Diseases
Metabolism, Inborn Errors
Pathologic Processes
Sex Differentiation Disorders
Steroid Metabolism, Inborn Errors
Interventions listed in this trial
Flutamide and Testolactone
Deslorelin
Additional drug interventions recognized in this trial
Flutamide
Testolactone
More general drug interventions related to this trial
Androgen Antagonists
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Enzyme Inhibitors
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Back to top of Main Content
